Ensign Peak Advisors, Inc Vir Biotechnology, Inc. Transaction History

Ensign Peak Advisors, Inc

$58.8 Billion
Q3 2025

A detailed history of Ensign Peak Advisors, Inc transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 554,981 shares of VIR stock, worth $3.12 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

554,981

Previous 63,874 768.87%

Holding current value

$3.12 Million

Previous $413,000 667.07%

% of portfolio

0.01%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$4.28 - $5.93 $2.1 Million - $2.91 Million	491,107 Added 768.87%	554,981 $3.17 Million
Q3 2024 Nov 14, 2024	BUY	$7.26 - $10.7 $98,736 - $145,520	13,600 Added 27.05%	63,874 $478,000
Q1 2024 May 14, 2024	SELL	$8.6 - $11.9 $21,809 - $30,178	-2,536 Reduced 4.8%	50,274 $509,000
Q4 2023 Feb 14, 2024	BUY	$7.76 - $10.29 $176,928 - $234,611	22,800 Added 75.97%	52,810 $531,000
Q3 2023 Nov 13, 2023	SELL	$9.14 - $24.62 $1.35 Million - $3.64 Million	-147,691 Reduced 83.11%	30,010 $281,000
Q1 2023 May 15, 2023	BUY	$22.26 - $30.85 $1.41 Million - $1.96 Million	63,511 Added 55.62%	177,701 $4.14 Million
Q4 2022 Feb 13, 2023	BUY	$19.96 - $28.22 $146,706 - $207,417	7,350 Added 6.88%	114,190 $2.89 Million
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $696,637 - $1.19 Million	38,151 Added 55.54%	106,840 $2.06 Million
Q2 2022 Aug 12, 2022	SELL	$19.08 - $26.7 $855,165 - $1.2 Million	-44,820 Reduced 39.49%	68,689 $1.75 Million
Q1 2022 May 16, 2022	BUY	$21.19 - $40.01 $62,298 - $117,629	2,940 Added 2.66%	113,509 $2.92 Million
Q4 2021 Feb 11, 2022	BUY	$30.97 - $54.03 $3.42 Million - $5.97 Million	110,569 New	110,569 $4.63 Million
Q4 2020 Feb 12, 2021	SELL	$25.51 - $43.38 $615,505 - $1.05 Million	-24,128 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$28.28 - $53.6 $525,385 - $995,780	18,578 Added 334.74%	24,128 $829,000
Q2 2020 Aug 12, 2020	BUY	$27.89 - $47.86 $154,789 - $265,623	5,550 New	5,550 $227,000

Others Institutions Holding VIR

# of Institutions

242

Shares Held

106M

Call Options Held

246K

Put Options Held

126K

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $747M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Vir Biotechnology, Inc. Transaction History